I'm working in one private laboratory in Hong Kong, one of our client is a stem cell bank company. The company have cord blood samples sent to us for ABO&Rh typing. I do not have any working experience in hospital or stem cell laboratory, so I have some questions about the cord blood samples for ABO testings: 1. Why the stem cell companies need to do the ABO&Rh typing on cord blood samples? Theoretically, the cord blood sample is not a baby's blood or mother's blood. If the companies need to know the baby's grouping, the better way is they can test on the baby's directly. Agree? 2. Most of the cord blood samples can give very clear-cut ABO results, however there is a few samples will give very questionable results, like mixed field (a small solid clump with cloudy background in tube method and displayed double cell populations in gel column). How can we report these samples and what further actions can be taken to protect ourself? We suggested the company repeat the test on baby's blood, but they refused. The reason is: it will border the client and will make the client query the cord blood sample is correct or not. 3. If the cord blood sample is Anti-D negative, it need to do weak D test or not? Thanks for your help.